Research Highlights: Significance of epigenetic modifiers in cancer progression: potential for therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research Highlights: Significance of epigenetic modifiers in cancer progression: potential for therapy
Authors
Keywords
-
Journal
Epigenomics
Volume 4, Issue 3, Pages 251-254
Publisher
Future Medicine Ltd
Online
2012-06-12
DOI
10.2217/epi.12.27
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2–Cul3–Rbx1 complex to allow normal Nrf2 activation and repression
- (2012) James W. Kaspar et al. JOURNAL OF CELL SCIENCE
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SOX9 expression and its methylation status in gastric cancer
- (2012) Minhua Sun et al. VIRCHOWS ARCHIV
- The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
- (2011) Tim J. Wigle et al. FEBS LETTERS
- EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
- (2010) I. Velichutina et al. BLOOD
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- The epigenome as a therapeutic target in prostate cancer
- (2010) Antoinette S. Perry et al. Nature Reviews Urology
- Drug discovery targeting epigenetic codes: The great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis
- (2009) Motoko Unoki et al. BIOCHEMICAL PHARMACOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
- (2008) Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma
- (2008) Masashi Fukayama et al. CANCER SCIENCE
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells
- (2008) Jong Kyong Kim et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now